Perrigo traded at $41.35 this Tuesday June 28th, decreasing $0.22 or 0.53 percent since the previous trading session. Looking back, over the last four weeks, Perrigo lost 3.74 percent. Over the last 12 months, its price fell by 10.42 percent. Looking ahead, we forecast Perrigo to be priced at 39.62 by the end of this quarter and at 35.19 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
41.35
Daily Change
-0.53%
Yearly
-10.42%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
AbbVie 151.61 -1.53 -1.00% 35.00%
Abbott 107.25 -1.83 -1.68% -8.50%
Bayer 60.23 0.83 1.40% 16.66%
Bristol-Myers Squibb 78.60 -1.38 -1.73% 18.61%
Coherus Biosciences 7.32 -0.31 -4.06% -47.86%
Corcept Therapeutics 24.20 -0.91 -3.61% 8.79%
Catalent 107.51 -3.36 -3.03% -1.50%
Dr.Reddys Laboratories 4,374.75 54.20 1.25% -19.48%
Endo International 0.77 0.39 101.38% -83.86%
Horizon Pharma 81.70 -3.80 -4.44% -13.88%
Jazz Pharmaceuticals 154.66 -2.03 -1.30% -13.61%
J&J 176.84 -5.28 -2.90% 7.81%
Lannett 0.61 -0.004 -0.62% -87.16%
Eli Lilly 317.19 -10.08 -3.08% 38.29%
Merck & Co 91.77 -2.64 -2.80% 18.86%
Nestle 110.64 -1.94 -1.72% -4.87%
Phibro Animal Health 19.11 -0.19 -0.98% -33.76%
Prestige Brands 57.06 -1.06 -1.82% 9.42%
Pacira 56.54 -0.67 -1.17% -6.82%
Pfizer 50.51 -1.37 -2.63% 29.19%
Powershares High Yield Orate Bond Portfolio 16.88 -0.13 -0.76% -13.61%
Perrigo 41.35 -0.22 -0.53% -10.42%
Reckitt Benckiser Group PLC 6,226.00 18.00 0.29% -3.10%
Sanofi 99.37 -0.22 -0.22% 12.50%
Supernus Pharmaceuticals 28.37 -0.62 -2.14% -10.31%
Teva Pharmaceutical Industries Ltd 2,831.00 141.00 5.24% -14.52%
United States Oil Fund 84.72 1.79 2.16% 69.81%
Xeris Pharmaceuticals Inc 1.57 -0.04 -2.48% -63.82%
Zoetis 170.77 -2.83 -1.63% -9.16%

Indexes Price Day Year
US500 3829 -71.42 -1.83% -10.79%
US400 2315 -27.47 -1.17% -14.08%

Perrigo
Perrigo Company plc is a provider of over the counter (OTC) health and wellness solutions that enables consumers to prevent or treat conditions that can be self-managed. The Company operates through two segments: Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises consumer self-care business (OTC, infant formula, and oral self-care categories, and contract manufacturing) in the United States (U.S), Mexico and Canada. CSCA segment products sold under brands, such as Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod and Firefly. The CSCI segment comprises consumer self-care business primarily branded in Europe and Australia, store brand business in the United Kingdom and parts of Europe and Asia. The CSCI segment primarily focuses on building local and regional brands sold through merchandisers, drug stores, pharmacies and e-commerce channels.